EchoMD Automated Ejection Fraction Software vs Cardio-TriTest

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoMD Automated Ejection Fraction Software

by Bay Labs (now Caption Health)

Cardio-TriTest

by Cardio-Phoenix

AI Verdict

Tool A specializes in automating the analysis of existing echocardiogram images to calculate ejection fraction, improving efficiency in cardiac evaluation. Conversely, Tool B is a multi-modal diagnostic device that combines ECG, PCG, and MCG to collect and analyze various heart bio-signals for broader cardiovascular disease detection. While both leverage AI in cardiology, they address different stages and types of cardiac assessment, making them adjacent rather than direct competitors.

Choose EchoMD Automated Ejection Fraction Software if…

Choose EchoMD Automated Ejection Fraction Software if your cardiology department regularly performs echocardiograms and aims to enhance the efficiency and standardization of Left Ventricular Ejection Fraction (EF) calculations. This tool is ideal for integrating seamlessly with existing DICOM PACS systems to automatically select optimal clips and reduce variability in EF measurements.

View EchoMD Automated Ejection Fraction Software →

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care or internal medicine clinic requires a comprehensive, non-invasive diagnostic device for earlier and more holistic cardiovascular disease detection. This 3-in-1 device is best suited for synchronizing and visually correlating ECG, PCG, and MCG bio-signals to provide a broader initial assessment of cardiac health.

View Cardio-TriTest →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoMD Automated Ejection Fraction Software	Cardio-TriTest
Pricing	Contact for pricing	Unknown
Deployment	On-premise (via DICOM PACS integration)	On-premise (device)
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoMD Automated Ejection Fraction Software

Tool A, EchoMD, excels in usability by fully automating echocardiogram clip selection and ejection fraction calculation, eliminating the need for manual intervention and reducing variability in a time-consuming process. Its seamless integration with DICOM PACS systems further streamlines existing clinical workflows.

Clinical Value

Cardio-TriTest

Tool B, Cardio-TriTest, offers significant clinical value by combining ECG, PCG, and MCG to provide earlier and more comprehensive cardiovascular disease detection in primary care. This multi-modal approach can identify structural and functional heart abnormalities that might be missed by standard ECGs, potentially leading to earlier interventions and improved patient outcomes.

Pricing & Value

Tie

Both Tool A and Tool B require users to contact the company directly for pricing information. Without transparent pricing or detailed return on investment (ROI) studies for either product, it is not possible to determine which offers better pricing or overall value.

Enterprise Readiness

EchoMD Automated Ejection Fraction Software

Tool A, EchoMD, demonstrates strong enterprise readiness through its on-premise deployment and seamless integration with existing DICOM PACS systems, a standard infrastructure in healthcare enterprises. This approach minimizes disruption and leverages established IT frameworks.

Innovation

Cardio-TriTest

Tool B, Cardio-TriTest, showcases greater innovation by integrating three distinct bio-signal modalities (ECG, PCG, MCG) into a single AI-powered device for synchronized and visually correlated heart analysis. This multi-modal diagnostic approach offers a novel method for comprehensive and earlier heart disease detection.

Support & Docs

EchoMD Automated Ejection Fraction Software

Tool A, through Caption Health, provides clear indications of accessible support channels, including a customer support email and user manuals that can be accessed directly from the software interface. In contrast, specific details about dedicated customer support or comprehensive public documentation for Tool B are less evident in available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoMD Automated Ejection Fraction Software	Cardio-TriTest
Name	EchoMD Automated Ejection Fraction Software	Cardio-TriTest v6.5
Company	Bay Labs (now Caption Health)	Cardio-Phoenix Inc.
Primary Function	AI to automatically select optimal echocardiogram clips and calculate left ventricular ejection fraction (EF)	AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG for cardiovascular disease detection
Key Technologies/Components	Deep learning algorithms for image analysis, automated clip selection, automated Left Ventricular Ejection Fraction (EF) calculation	3-in-1 diagnostic device (ECG, PCG, MCG), 12-Lead Electrocardiograph (ECG), 4 Lead Phonocardiograph (PCG), 4 Lead Mechanocardiograph (MCG)
Main Output/Benefit	Automated Left Ventricular Ejection Fraction (EF) calculation, reduced variability, increased efficiency in echocardiogram interpretation	Synchronized and visual correlation of heart bio-signals for earlier and more comprehensive cardiovascular disease detection
Specialties	Cardiology, Critical Care, Emergency Medicine, Radiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring EchoMD Automated Ejection Fraction Software and Cardio-TriTest.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does EchoMD's automated clip selection and EF calculation integrate into an existing echocardiography reading workflow, and what is its direct impact on diagnostic efficiency and confidence?

EchoMD's automated clip selection and EF calculation streamlines the echocardiography reading workflow by eliminating the need for manual intervention and reducing variability in measurements. This seamless integration with DICOM PACS systems allows clinicians to focus more on contextualizing results for patient prognosis and management, thereby enhancing diagnostic efficiency and confidence.

For primary care physicians, how does Cardio-TriTest's 3-in-1 diagnostic approach (ECG, PCG, MCG) enhance or alter the current cardiovascular screening and early detection workflow?

Cardio-TriTest, also known as Cardio-HART, enhances primary care cardiovascular screening by offering echo-level insights in minutes at the point of care through its combined ECG, PCG, and MCG analysis. This multi-signal approach functions as a triage and diagnostic support tool, helping physicians detect structural heart disease and heart failure indicators earlier, and can reduce unnecessary referrals to echocardiography by up to 66%.

What specific accuracy, sensitivity, and specificity metrics are available for EchoMD's automated EF calculation, and for Cardio-TriTest's detection of various cardiovascular conditions?

EchoMD AutoEF demonstrates superior accuracy with less variability (8.29%) in EF measurement compared to the average cardiologist (9.2%) using the Simpson's biplane method. Cardio-TriTest (Cardio-HART) shows over 90% sensitivity for heart failure across the EF spectrum, 96% agreement with Simpson Biplane LVEF measurements, and can detect up to 94% of common heart diseases by prevalence in primary care.

What is the depth of EHR integration for each tool, specifically regarding automated transfer of AI-generated results, and what audit-trail features are available for tracking AI analyses and user interactions?

EchoMD integrates seamlessly with DICOM PACS systems and offers pre-built connectors for major EHR systems, automating data entry and forwarding results for clinician viewing. While specific AI-driven audit trail details for both tools are not extensively detailed, EchoMD mentions continuous monitoring and audits for data integrity, and general EHR systems provide audit trails for user actions and data access.

What is the expected learning curve for clinical staff to effectively utilize each system, and what are the key considerations for a successful multi-site rollout, particularly regarding training and data synchronization?

EchoMD, as part of Caption AI, is designed for a low learning curve, enabling clinicians, even those without prior ultrasound experience, to acquire diagnostic-quality images with real-time guidance. Cardio-TriTest (Cardio-HART) is described as 'nurse-led, repeatable, and low-operator-dependence,' making it suitable for multi-site rollouts in community diagnostic hubs, with trials involving multiple sites to ensure generalizability and facilitate training.

How do the distinct functionalities of EchoMD, focused on a specific echocardiographic measurement, and Cardio-TriTest, with its multi-signal diagnostic approach, address the unique clinical needs within their target specialties?

EchoMD offers specialized utility for cardiologists, critical care, and emergency medicine by automating a critical echocardiographic measurement (EF), improving efficiency and consistency in cardiac evaluation. Cardio-TriTest provides a broader diagnostic approach for primary care, family medicine, and internal medicine, enabling earlier and more comprehensive detection of various cardiovascular conditions through its multi-signal analysis, thereby optimizing referrals to specialists.